Cargando…
RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway
Prostate cancer (PCa) morbidity in the majority of patients is due to metastatic events, which are a clinical obstacle. Therefore, a better understanding of the mechanism underlying metastasis is imperative if we are to develop novel therapeutic strategies. Receptor activator of nuclear factor kappa...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190078/ https://www.ncbi.nlm.nih.gov/pubmed/34108600 http://dx.doi.org/10.1038/s41598-021-91721-2 |